- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
NoDoughBro
(69.71)
Submitted: 4/29/2013 9:57:21 AM :
Start Price:
$2.63
GALE Score:
-5.31
I swear. I'm the worst trader for my kid. I soon as I get out. The stock explodes. Getting back into GALE for the 3rd time this year. Just got of ATHX. Watch what happens to ATHX.
Recs
DougD720
(< 20)
Submitted: 4/15/2013 12:01:53 PM :
Start Price:
$2.18
GALE Score:
+13.67
Outperform due to new acquisitions which will generate cash (rarity for a research-phase biopharm company) and their lead drug candidate NeuVax.
Recs
Skylar0614
(71.41)
Submitted: 3/20/2013 1:04:42 PM :
Start Price:
$1.95
GALE Score:
+26.90
Ready for a turnaround
Recs
robotclo
(55.25)
Submitted: 3/18/2013 5:19:17 AM :
Start Price:
$2.06
GALE Score:
+19.02
Teamed up with TEVA for the phase 3 drug trials. That's a solid endorsement.
Recs
scrubs62074
(79.50)
Submitted: 2/19/2013 4:00:53 PM :
Start Price:
$2.08
GALE Score:
+16.96
High Volume breakout on 02/19/13
Recs
anchor68
(68.14)
Submitted: 1/9/2013 9:00:20 PM :
Start Price:
$1.86
GALE Score:
+27.03
This stock wouldn't have gotten Teva Pharmaceuticals interested if the results weren't solid. I can't imagine this stock being lower than $2 for long. Great entry point right now!
Recs
cmrk3
(40.86)
Submitted: 1/4/2013 4:51:55 PM :
Start Price:
$1.86
GALE Score:
+24.58
I hate breast cancer.
Recs
Haaldan
(76.57)
Submitted: 12/19/2012 7:25:31 AM :
Start Price:
$1.58
GALE Score:
+50.87
Great time to buy. I don't see the stock getting much cheaper any time soon.
Recs
ayuddha
(< 20)
Submitted: 7/15/2012 5:18:50 PM :
Start Price:
$1.68
GALE Score:
+32.60
It was picked by www.hechtsoft.de Trade Alerts.
Recs
phatchips767
(< 20)
Submitted: 6/27/2012 8:42:25 PM :
Start Price:
$1.64
GALE Score:
+33.47
porto.likedededd it
Recs
4DogsPA
(23.53)
Submitted: 6/26/2012 3:06:15 PM :
Start Price:
$1.79
GALE Score:
+20.16
Drug NueVax in Phase III trials with very promising results for breast cancer.
Recs
stainsolution
(< 20)
Submitted: 4/5/2012 11:48:44 AM :
Start Price:
$1.60
GALE Score:
+44.40
Going long here----dropped on the Share Offerring/Dilution.
Recs
RBuskey106
(< 20)
Submitted: 4/5/2012 11:47:26 AM :
Start Price:
$1.60
GALE Score:
+44.40
Chart Play + Long Play
Recs
Itchy16
(< 20)
Submitted: 3/27/2012 11:03:45 AM :
Start Price:
$1.93
GALE Score:
+17.82
Some real potential here long term for patients and investors alike.
"Save the Ta-tahs!"
Recs
geomedf
(< 20)
Submitted: 3/26/2012 3:46:15 AM :
Start Price:
$2.35
GALE Score:
-6.99
Engaged in RNA targeted solutions and just received patent for very promising breast cancer drug (Neuvax) in phase III testing that may benefit 50-70% of breast cancer patients.
Recs
Indievestor
(24.21)
Submitted: 3/5/2012 9:00:14 PM :
Start Price:
$1.68
GALE Score:
+32.52
Biotech with good Insider buying and a solid candidate drug. Look for gains to $2 or more in the short-term.
Recs
HGpm
(< 20)
Submitted: 3/2/2012 10:49:18 AM :
Start Price:
$1.44
GALE Score:
+60.44
RXi Pharmaceuticals (RXII) provided a positive NeuVax phase 3 clinical trial update.
In the report, it was stated that RXi satisfied all requirements specified by the FDA and subsequently initiated a clinical trial material manufacturing plan to remain on schedule to meet the planned trial start date.
Recs
Momentum22
(30.38)
Submitted: 2/3/2012 10:20:16 PM :
Start Price:
$2.06
GALE Score:
-1.89
I had written this little guy off for dead...not even a green thumb in my M21 account but a real life position. That's how I roll baby...
I got so excited about THLD today that I didn't get to celebrate this strong day up 30%...still a ways to go but something is stirring here for sure! fly little gale, fly...
Recs
portefeuille
(99.78)
Submitted: 12/15/2011 11:14:21 PM :
Start Price:
$0.75
GALE Score:
+213.56
There are currently 7500 GALE shares in my "fund" with break-even of around 4.68 USD. http://caps.fool.com/Blogs/fund-trades/678775.
Recs
zzlangerhans
(99.79)
Submitted: 12/6/2011 1:25:09 PM :
Start Price:
$0.51
GALE Score:
+375.65
This is just a wild swing at a problematic little biotech hitting the 0.5 CAPS threshold. I don’t have a good explanation for why I’m green thumbing it here, other than I think they can remain solvent until they can get their phase III NeuVax breast cancer immunotherapy trial up and hyping.
From a recent PR:
In September, Galena announced a strategic transaction involving its new RXi Pharmaceuticals Corporation subsidiary. As part of the strategic transaction, the company contributed its RNAi program to RXi and changed its name from RXi Pharmaceuticals to Galena Biopharma to reflect its focus on developing its portfolio of targeted cancer therapies.
From Wikipedia:
Galena is the natural mineral form of lead sulfide. The crystals are bright when fresh but often receive a dull tarnish after exposure to air. Galena is often mined for its silver content. One of the oldest uses of galena was as kohl, which, in Ancient Egypt, was applied around the eyes to reduce the glare of the desert sun and to repel flies, which were a potential source of disease.
Galena is the county seat of, and largest city in, Jo Daviess County, Illinois in the United States, with a population of 3,429 in 2010. The city is a popular tourist destination known for its history, historical architecture, and ski and golf resorts. Galena was the residence of Ulysses S. Grant as well as several other war generals, entertainers, and politicians.
If you know how the name Galena reflects the company’s focus on targeted cancer therapies, then you’ve been dipping into the same stash of shrooms as Galena’s CEO. Where can I get some?
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 28 : 1 2 Next »